Breaking

China has spent billions developing military tech. Conflict between India and Pakistan could be its first major test
Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade
Ellen Miles is planting seeds of hope through guerrilla gardening
Sycamore Gap: Two men convicted of felling one of UK’s most famous trees
Ukraine says it has uncovered Hungarian spy network working in border region
US and other allies of Ukraine pile pressure on Putin, threatening fresh sanctions if he refuses 30-day truce
Diver dies in preliminary operations to recover tech tycoon’s sunken superyacht
Rodrigo Duterte is being held at The Hague. Next week he might be elected mayor of his hometown

Politics
World
Investing
Business
Search for:

Investing

Completion of preclinical data package for RAD 402

December 10, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

7 Copper ETFs and ETNs

Crypto Market Recap: Bitcoin Breaks US$100,000 as ETF Inflows Rise, Coinbase Makes US$2.9 Billion Power Play

Metals and Mining Virtual Investor Conference: Presentations Now Available for Online Viewing

Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!

Your name
Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,267)
- Investing (3,005)
- Politics (3,997)
- World (3,871)

Disclaimer: FinancesDataDriven.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest Posts

Copyright © 2025 financesdatadriven.com | All Rights Reserved

Top

Politics
World
Investing
Business

Type above and press Enter to search. Press Esc to cancel.